Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ANGO +6.2%, MCHP +4.2% (guidance)
Other news:
- DRUG +50% (to announce topline results for BMB-101 Phase 2 trial)
- AEVA +24% (selected as reference LiDAR sensor for NVIDIA (NVDA) DRIVE Hyperion platform)
- ALMS +17.2% (to report Phase 3 ONWARD topline data)
- ZETA +10.6% (strategic collaboration with OpenAI)
- OCS +9.4% (receives FDA Breakthrough Therapy Designation for Privosegtor in optic neuritis)
- ABP +6.2% (Abpro and Celltrion receive US FDA IND clearance for ABP-102 / CT-P72)
- CVI +4.9% (capital spending guidance)
- VST +4.6% (to acquire Cogentrix Energy)
- NBP +4.6% (presents givastomig dose expansion data from the Phase 1b combination study in patients with 1L metastatic gastric cancer)
- EP +4.1% (extends $20.0 million revolving credit facility through 2028)
- GANX +4% (highlights biomarker evidence supporting disease-modifying potential of GT-02287)
- UAA +3.3% (Fairfax Financial discloses 22.2% stake)
- ALKS +3.1% (granted breakthrough therapy designation by U.S. FDA for the treatment of narcolepsy type 1)
- BORR +2.8% (secures new jack-up rig contract extensions in the Americas)
- GSK +2.5% (announces Exdensur approved in Japan for severe asthma and CRSwNP)
- IPI +2.3% (progress in partnership to develop a lithium project in Utah)
- JXN +2.1% (Jackson Financial and TPG Inc (TPG) announce long-term strategic partnership; Jackson will receive a $500 million common equity investment from TPG)
- CRWV +2% (adds NVIDIA (NVDA) Rubin platform to AI cloud roadmap)
- VEEV +1.9% (authorizes new $2 bln share repurchase program)
- ACRS +1.9% (interim results of phase 1a Trial of Anti-TSLP/IL-4Ra bispecific antibody ATI-052)
- SMCI +1.6% (expands liquid-cooled ai infrastructure support for nvidia vera rubin and rubin platforms)
- CAAS +1.6% (announces 2026-2030 strategic plan)
- IR +1.5% (acquires Scinomix)
- NBIS +1.4% (to deploy NVIDIA Vera Rubin NVL72 across U.S. and Europe starting H2 2026)
- CRNC +1.2% (Cerence xUI gains traction with automakers using NVIDIA AI Enterprise on Microsoft Azure)
- LCID +1.1% (Lucid Group, Nuro and Uber unveil global robotaxi, begin autonomous on-road testing)